IL17A and endothelial dysfunction: The first of these mechanisms is via upregulated expression of interleukin 17 (IL-17) which has been shown to increase the formation of reactive oxygen species and inflammatory leucocytes within the circulation resulting in endothelial dysfunction and raised systolic blood pressure.